SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

13 Nov 2024 Evaluate
A decent increase of about 56.21% in the turnover to Rs. 932.90 millions was observed for the quarter ended September 2024. The turnover stood at Rs. 597.20 millions during the similar quarter previous year.The Total Profit for the quarter ended September 2024 of Rs. 142.50 millions grew from Rs.-57.80 millionsOperating profit surged to 373.30 millions from the corresponding previous quarter of 357.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 932.90 597.20 56.21 1967.00 1292.70 52.16 3273.50 4025.50 -18.68
Other Income 239.30 387.10 -38.18 355.20 531.50 -33.17 630.50 521.60 20.88
PBIDT 373.30 357.90 4.30 638.20 452.10 41.16 698.50 599.20 16.57
Interest 155.90 174.20 -10.51 313.20 351.80 -10.97 681.90 579.20 17.73
PBDT 217.40 153.20 41.91 325.00 69.80 365.62 -13.90 0.00 0.00
Depreciation 163.00 245.80 -33.69 326.20 492.70 -33.79 1016.10 962.00 5.62
PBT 54.40 -92.60 -158.75 -1.20 -422.90 -99.72 -1030.00 -962.00 7.07
TAX -88.10 -34.80 153.16 -109.00 -151.80 -28.19 -265.90 -373.30 -28.77
Deferred Tax -88.10 -34.80 153.16 -109.00 -151.80 -28.19 -376.50 -373.30 0.86
PAT 142.50 -57.80 -346.54 107.80 -271.10 -139.76 -764.10 -588.70 29.79
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 313.60 0.00
PBIDTM(%) 40.02 59.93 -33.23 32.45 34.97 -7.23 21.34 14.89 43.35

Dishman Carbogen Amc Share Price

167.55 -1.05 (-0.62%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×